000 | 01943 a2200505 4500 | ||
---|---|---|---|
005 | 20250517082308.0 | ||
264 | 0 | _c20180227 | |
008 | 201802s 0 0 eng d | ||
022 | _a1435-1463 | ||
024 | 7 |
_a10.1007/s00702-016-1527-4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBaysal, Ipek | |
245 | 0 | 0 |
_aDonepezil loaded PLGA-b-PEG nanoparticles: their ability to induce destabilization of amyloid fibrils and to cross blood brain barrier in vitro. _h[electronic resource] |
260 |
_bJournal of neural transmission (Vienna, Austria : 1996) _c01 2017 |
||
300 |
_a33-45 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAmyloid _xdrug effects |
650 | 0 | 4 |
_aAmyloid beta-Peptides _xmetabolism |
650 | 0 | 4 |
_aAstrocytes _xdrug effects |
650 | 0 | 4 |
_aBlood-Brain Barrier _xdrug effects |
650 | 0 | 4 |
_aCapillary Permeability _xdrug effects |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aCholinesterase Inhibitors _xadministration & dosage |
650 | 0 | 4 | _aDonepezil |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Carriers |
650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
650 | 0 | 4 |
_aGene Expression _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndans _xadministration & dosage |
650 | 0 | 4 |
_aNanoparticles _xultrastructure |
650 | 0 | 4 |
_aNeuroprotective Agents _xadministration & dosage |
650 | 0 | 4 |
_aPeptide Fragments _xmetabolism |
650 | 0 | 4 |
_aPiperidines _xadministration & dosage |
650 | 0 | 4 | _aPolyethylene Glycols |
650 | 0 | 4 | _aPolyglactin 910 |
650 | 0 | 4 |
_aProtein Stability _xdrug effects |
650 | 0 | 4 |
_aRifampin _xpharmacology |
700 | 1 | _aUcar, Gulberk | |
700 | 1 | _aGultekinoglu, Merve | |
700 | 1 | _aUlubayram, Kezban | |
700 | 1 | _aYabanoglu-Ciftci, Samiye | |
773 | 0 |
_tJournal of neural transmission (Vienna, Austria : 1996) _gvol. 124 _gno. 1 _gp. 33-45 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00702-016-1527-4 _zAvailable from publisher's website |
999 |
_c25766219 _d25766219 |